Xeris Biopharma Holdings, Inc.XERSNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$28.63M
↑ 154% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-53.43M
Historical baseline
PeriodValueYoY Change
2025$28.63M+177.4%
2024$-36.98M+21.4%
2023$-47.02M+54.3%
2022$-102.89M0.0%
2021$-102.89M-7.7%
2020$-95.53M-18.6%
2019$-80.56M-43.1%
2018$-56.28M-128.2%
2017$-24.66M-53.3%
2016$-16.09M-